Page last updated: 2024-11-10

octabromobiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

octabromobiphenyl: fire retardant; 27858-07-7 (cpd with unspecified bromine locants) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3032840
SCHEMBL ID1352858
MeSH IDM0057062

Synonyms (20)

Synonym
bb-8
octabromobiphenyl
tetrabromo(tetrabromophenyl)benzene
octabromodiphenyl
einecs 248-696-7
hsdb 7350
biphenyl, octabromo-
ar,ar,ar,ar,ar',ar',ar',ar'-octabromo-1,1'-biphenyl
1,1'-biphenyl, ar,ar,ar,ar,ar',ar',ar',ar'-octabromo-
1,2,3,4,5-pentabromo-6-(2,3,4-tribromophenyl)benzene
unii-64i1q073mf
27858-07-7
64i1q073mf ,
SCHEMBL1352858
4E96M09888
pbb 195
2,2',3,3',4,4',5,6-octabromobiphenyl
DTXSID40871357
2181003-05-2
Q27259482

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (55.56)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.83 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]